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Epidermolytic hyperkeratosis is an autosomal dominant ich-
thyosis characterized by blistering, especially at birth and 
during childhood, and hyperkeratosis. Epidermolytic hyper-
keratosis presents striking clinical heterogeneity, particularly 
between families. Several avenues of research have impli-
cated an abnormality of epidermal differentiation in the 
pathogenesis of this disease. In a three-generation family 
with 20 affected individuals, we tested a variety of candidate 
loci and identified linkage to the type II keratin region on 
chromosome 12. Further investigation revealed a mutation 
in the H1 subdomain of the keratin 1 gene as the cause of 
EHK in this family. Because keratin 10 is the co-expressed 
partner of keratin 1, it was not surprising when abnormalities 
H istorically, the clinical classification of skin disease was the mainstay of dermatology. A first step in understanding the etiology of skin diseases was to define the clinical spectrum of disorders to deter-mine which presentations were manifestations of 
the same disease, and which identified different conditions. In these 
early attempts to understand disease processes the main tools were 
observation, description, and classification. The development of 
various medical and scientific disciplines created tools to probe the 
mechanisms underlying disease pathogenesis. Advances in microbi-
ology allowed the identification of organisms involved in infectious 
diseases, such as syphilis, resulting in a better understanding of the 
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osis vulgaris; KIF, keratin intermediate filaments; LI, lamellar ichthyosis; 
NPS, no palm/sole hyperkeratosis; PS, palm/sole hyperkeratosis; XLR, X-
linked recessive (ichthyosis). 
in keratin 10 were found in other families with EHK. We 
have examined 52 patients from 21 families and have identi-
fied at least six clinical phenotypes. The most useful distin-
guishing feature was the presence or absence of severe hyper-
keratosis of the palms and soles. We and others are 
continuing to search for and characterize mutations in kera-
tin 1 and 10 in patients with epidermolytic hyperkeratosis. 
Correlation of the clinical disease types with the specific 
mutations should lead to a better understanding of the rela-
tionship between keratin structure and function in normal 
and diseased epidermis. Key words: ichthYOSis/keratin/genoder-
matosis.] Invest Dermatol102:390-394, 1994 
pathogenesis of several diseases. Through dermatopathology, d~r­
matologists had an additional perspective to understand and claSSify 
diseases. Similarly, understanding the biochemical alterations un-
derlying the metabolically induced dermatoses, such as the por-
phyrias, led to elucidation of their etiology. With the maturing of 
molecular genetics the ability to categorize diseases based upon the 
specific underlying gene mutation has become a reality. 
OVERVIEW OF THE ICHTHYOSES 
Ichthyosis is a general term used to describe a heterogeneous groUP 
of skin disorders. The term is derived from the Greek word for fish, 
ichth),s, and relates to the characteristic dry, scaly appearance of the 
skin in these conditions. Ichthyosis may be acquired, for example, 
resulting from cancer, endocrine disease, or severe nutritional defi-
ciencies. However, most types of ichthyosis have a genetic basis and 
present at birth. Unfortunately, little is known about the pathogel~­
esis of the ichthyoses. In x-linked ichthyosis the pattern of inheri-
tance is known, as is the underlying abnormality, steroid sulfatase 
deficiency. However, what is unknown is the mechanism through 
which this enzyme deficiency leads to the clinical presentation of 
ichthyosis. 
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Classification schemes for the ichthyoses have been proposed 
based on clinical features, pattern of inheritance, or histology and 
cell kinetics. Williams and Elias define twenty-four "disorders of 
cornification" in which clinical, genetic, or biochemical data 
strongly suggest a distinct genetic entity [1]. However, no single 
schema has been universally accepted. 
. On a practical basis, when a patient presents to a physician, the 
disease is often characterized clinically based on appearance and 
pattern of inheritance. The most common ichthyoses inherited as 
aUtosomal dominant traits include ichthyosis vulgaris (IV) and epi-
dermolytic hyperkeratosis (EHK). In contrast, lamellar ichthyosis 
~LI) and congenital ichthyosiform erythroderma (CIE) are inherited 
In an autosomal recessive manner. Steroid sulfatase deficiency is an 
X-linked recessive ichthyosis. In addition to these, there are several 
Ichthyoses observed in association with syndromes. 
. IV is the most common of the hereditary scaling disorders, affect-
I~g one in 250-300 persons. As an autosomal dominant trait, the 
n.sk to each offspring of an affected parent is 50%. Clinically, the 
disease is usually not present at birth, but presents in the first year. 
Sbn involvement in IV is usually mild and manifested by xerosis 
a.nd a fine, white scale. IV is notable for its widely variable expres-
Sion, even within affected members of the same family . Histopatho-
logic examination of affected skin frequently reveals a decreased or 
akbsent granular layer [2]. The molecular basis of the disease is un-
nown to date. 
EHK, also known as bullous congenital ichthyosiform erythro-
derma, occurs in 1 : 200,000 - 300,000 people. As many as one half 
the cases of EHK represent new mutational events, where both 
parents are unaffected [3]. The disorder is evident at birth, and may 
present with blistering, redness, and peeling. Over time patients 
develop a generalized hyperkeratosis. In contrast to the other ich-
t?yoses, the histopathologic picture ofEHK is distinctive, and con-
Sists of epidermal hyperkeratosis with a characteristic degeneration 
of the granular layer. 
.~- linked recessive (XLR) ichthyosis was distinguished from the 
chmcally similar, but more common, IV by clinical and pedigree 
itudies [4,5]. This disease occurs almost exclusively in males, with at 
~ast 1 : 6000 males being affected. Manifestations ofXLR ichthyo-
SIS a.re not always confined to the skin and may include asympto-
matic corneal opacities and cryptorchidism [6,7]' The underlying ~Iochemical defect in XLR ichthyosis is a deficiency of steroid sul-
atase [8] . 
~utosomal recessive LI affects approximately 1 : 300,000 people. 
rktlellts present at birth, often as "collodion babies." Large, plate-
I e, brown scales develop and cover the entire body. The disease 
often leads to ectropion and scarring alopecia, and hypohidrosis may 
cause heat intolerance. 
.CIE, also an autosomal recessive congenital ichthyosis, may be 
chhnlcally distinguished from LI. Although CIE may present with 
t e collodion phenotype, affected individuals have erythroderma, 
and scales that are finer and whiter than that seen in LI. 
~ole~ular Genetics: A Tool to Understand Disorders of 
ornlfication Current classifications of the ichthyoses, based 
;:n ~linical presentation and pattern of inheritance, are useful 
Ut Imprecise. Studies directed at assessing cell proliferation rates 
an.d. defining specific histologic features have also been of limited ~tlhty in defining and separating the disorders. A better classifica-
tlon . of the ichthyoses wopld be based upon identification of the 
specific underlying defect in each disorder. A direct biochemical 
approach has identified the cause ofXLR ichthyosis as steroid sulfa-
~ase defiCiency [9,10]. This knowledge of the underlying enzymatic 
. ~ect is used to establish the diagnosis. Except for a few other rare 
l~ t]hyoses (Refsum's disease, inability to degrade phytanic acid 
t 1 ; .Chanarin-Dorfman syndrome, disorder of neutral lipid me-
abohsm [12-14]; multiple sulfatase deficiency [15]), biochemical 
Y
markers have not been found for the other more common ichth-
oses. 
n ~ di~erent, less direct approach to learning the etiology of ge-
etlc disorders is to first identify the chromosomal location of the 
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causative gene and subsequently to search for its function. Genetic 
linkage analysis is a statistical method that involves analyzing fami-
lies with the disease along with genetic markers whose chromo-
somal location is known. This allows the localization of the disease 
locns within a genetic map of the markers used. This map is the 
result of determining in offspring the frequency of recombination 
that occurred during parental meiosis that produced gametes. The 
estimate of the distance between the disease locus and the markers 
(or between the markers themselves) is derived from observation of 
the frequency of meiotic recombination. Markers that are inherited 
with the disease tend to be located in close physical proximity to the 
disease gene. Markers that are distant from the disease locus are 
more likely to have undergone recombination with the disease gene 
during meiosis. Markers can be genes with known function (i.e., 
genes for cell surface markers [HLA, ABO blood group], enzymes, 
serum proteins) or they may be random pieces of DNA whose 
location is all that is known. If there are specific genes of known 
function that are suspected to be involved in the etiology of the 
disease, i.e., candidate genes, they may also be used as genetic link-
age markers. 
Linkage analysis does not allow specific identification of the 
physical location of the gene, only its genetic relationship to known 
markers. However, once the general location of the disease gene is 
known, other studies (i. e., physical mapping includirIg chromo-
some walking and jumping) may allow for identification of the 
disease gene itself. The gene may then be cloned, characterized, and 
sequenced, and its function sought. 
Information derived from a variety of approaches, including his-
tology, ultrastructure, and molecular genetic studies in mice and 
humans have led to the recent identification of the underlying de-
fects in one ichthyosis, epidermolytic hyperkeratosis. 
Epidermolytic Hyperkeratosis-Clinical and Histologic Features: EHK 
is characterized by blistering, especially at birth and during child-
hood, and hyperkeratosis. EHK presents striking clinical heteroge-
neity between families, particularly regarding extent of body 
surface involvement, quality of scale, presence or absence of 
erythroderma, and palmar/plantar involvement. Histologic exami-
nation of hematoxylin-eosin stained sections of EHK skin show a 
tremendously thickened stratum corneum and vacuolar degenera-
tion of the upper epidermis, leading to the histologic term "epi-
dennolytic hyperkeratosis." Granular cells exhibit dense, enlarged, 
irregularly shaped masses that appear to be keratohyalirI granules 
[16]. 
On electron microscopic examination, clumping of filaments is 
observed to begin in the first suprabasallayer [17J . These aggregated 
filaments have been demonstrated to be clumps of keratin interme-
diate .filaments [1] that contain the terminal differentiation specific 
keratins 1 and 10 [18]. In some patients with EHK, these aggregated 
tonofilaments are arrayed in a shell-like formation around the cell's 
nucleus. ~n ultrastructure examination of a fetal sample, the 
clumps varied 111 density and had a repetitive periodicity. They are 
indistinguishable from the clumps observed in the Dowling-Meara 
type of epidermolysis bullosa simplex (EBS) [19]. 
Candidate Genes for EHK These light and electron micro-
scopic studies have identified certain candidate genes as possibly 
being involved in the etiology ofEHK. These studies point toward a 
defect in a terminal differentiation-specific epidermal gene product 
that could cause keratin intermediate filament disorganization, in-
creased numbers of keratohyalin granules, and vacuolated granular 
cells. Several epidermal genes have expression patterns that are co-
incident with the pathologic alterations in EHK. These genes irI-
clude the two keratins that are expressed in the suprabasal epidermis 
(keratin 1 and keratin 10) [20 -22]. Keratin 1 and keratin 10 are 
expressed together in the cells of the suprabasallayers of the epider-
mis, and both are required to form keratin intermediate filaments 
(Fig 1). The genes for profilaggrin [23,24]' loricrin [25,26], involu-
crin [27], and transglutaminase K [28] are also expressed coincident 
with EHK pathology. Loricrin and involucrin are components of 
the cell envelope and trans glutaminase K is involved in cell enve-
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Figure 1. Schematic representation of keratin protein interaction. The 
genes for type I (acidic) keratins are located on chromosome 17 and t~e 
genes for type II (neutral-basic) keratins are on chr?mosome 12. Keratm 
heterodimers are formed by the interaction of a specific type I keratm (,.e., 
keratin 10) with a specific type II keratin (i.e., k.eratin 1). Keratin interme-
diate filaments are formed from higher-order mteractlOns of the hetero-
dimers. 
lope assembly. The genes for each of these candidates have been 
cloned and characterized. 
Another clue to the etiology of EHK came from the similarity 
observed in the filament clumping in this diseas~ and epidermolysis 
bullosa simplex (EBS). The discovery that EBS IS caused by a defect 
in either of the basal specific keratins, keratin 14 or kerati.n 5 [29], 
suggested that the keratins expressed s~prabasally, keratIn 1 and 
keratin 10, were particularly good candidates for EHK. . . 
Models using transgenic mice have prove? useful for lf~VeStigat­
ing whether alterations in expressIOn of epI~ermal kerat~ns could 
have pathologic consequences. Transge~c mIce ~re genetically en-
gineered to express a gene that has been Inserted Into their genome 
by an investigator. Vassar et al [30] rep~rted that a. trans gene for. a 
truncated keratin 14, when expressed m b~sal .ep~de:~al cells In 
mice, caused a phenotype with morphologic slmll~ntles to EBS. 
Transgenic mice expressing a similar truncate~ keratIn 14 construct 
but in terminally differentiating suprabasal epidermal layers caused 
pathology reminiscent of EHK [31] . . 
The candidate genes identified from these stud.les l~ave been used 
as markers in genetic linkage analysis to determIne If any of these 
genes are linked to the disease locus. 
Genetic Linkage Analysis in EHK Compt?n et al [32] de-
scribed a large family in which EHK was segregatl~g t~lfough three 
generations. This family was used to test for genetic lInkage of the 
gene causing EHK to several candidate loci. T~ere were 20 affe~ted 
individuals in this family who had limited dls~ase, ~haracte~lzed 
primarily by congenital palmar and plantar thickenIng .. Patients 
had limited involvement of the flexures and truncal sparmg. The 
palmar/plantar hyperkeratosis had a sharp border that was deline-
ated by a red halo. In some patients the thick, smooth hyper~era­
tosis caused restriction of digital and palmar extension. Blister-
ing was more severe in infancy and childhood, ~nd dec~eased .in 
adulthood. However, many adults did report blisters With mild 
trauma. The younger patients in the family had moderate flexural 
surface involvement and were more severely affected than the 
adults. Most affected family members had hyperkeratotic scale at 
the corners of the lips, sometimes continuing onto the buccal mu-
cosa. 
THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
The genes for transglutaminase K, loricrin, profilaggrin, and 
keratin 10 in this family were tested for linkage with the EHK locus. 
Because there was genetic recombination (meiotic crossover) be-
tween each of these candidate genes and the disease locus, each 
could be excluded as the disease causing gene. However, there was 
no recombination between the disease and the locus for keratin 1, 
a member of the group of neutral-basic (type II) keratins. The 
type II keratin genes reside in a cluster located on the long arm 
of chromosome 12 [33 - 35]. Use of several random DNA marke~s 
located in the region of the type II keratin loci confirmed thiS 
finding. T 
Fourteen affected individuals from three other EHK faml les 
were studied by Bonifas et al [36]. Each provided some evidence for 
linkage to markers on chromosome 12q, although the keratlll 1 
gene itself was not used as a marker in that study. Link~ge to mar~e:s 
on chromosome 17q, in the region of the type I keratInS (the aCidiC 
keratins that include keratin 10), was strongly excluded 111 those 
families. 
Identification of Keratin Mutations in EHK Chipev et at [37] 
sequenced the coding regions of both keratin 1 alleles of one patient 
in the family reported by Compton et al [32]. A single base patr 
substitution in one allele was identified. This alteration causes a 
non-conservative amino aci~ change in cod.on 160 from l~ucine ti 
proline in the H1 subdomaIn of the kerat1l1 1 gene. Clllpev et ~ 
determined that one keratin 1 allele of every affected member in thiS 
family had the proline substitution, whereas all unaffected members 
had two unsubstituted (normal) alleles. It w~s co.nceivable ~ha~ t.ld~ 
proline substitution was merely a po!ymorplllsm1l1 ~ormal111dlv.1 
uals that, by chance, was segregatIng With EHK 111 tim faml.ly. 
Therefore, a further 100 alleles (from 50 normal control 10-
dividuals) were tested. None was found to have the mutant 
allele. 
Although the genetic data strongly supported keratin 1 as the 
disease gene, linkage analysis alone cannot distinguish between a 
closely linked marker and a true disease-causing mutation. It waS 
necessary to demons.trate that the mutation altered. kerati.n 1 g~n~ 
function. It had preVIOusly been shown that synthetiC peptJdes Wit 
amino acid sequences corresponding to the principal overlap re-
gions of keratin 1/keratin 10 keratin intermediate filalT~ents (KIF) 
can disassemble preformed KIF in vitro [38 ,39]. A functIonal assay 
was developed to study the effect of mutated keratin peptides on 
preformed KIF [37] . Synthetic peptides representing either the no~­
mal or proline-substituted keratin 1 sequence were tested for t~elr 
effect on the stability of pre-formed KIF. The rate of disaggregatiOn 
of KIF was measured by light scattering and electron microsc~pY' 
Whereas the normal peptide caused rapid disassembly, the pr~11l1e: 
substituted peptide didso much more slowly. This ~bn?rmallllte~e 
action of mutated peptide With filaments observed trt vItro could 
extrapolated in vivo into diminished stability of intermediate fila-
ments containing mutant keratin 1 chains. 
EHK mutations in small families, or in new occurrences of the 
disease, are not amenable to gene-linkage analysis. Instead, direct 
analysis of the keratin gene may identify probable disease-causmg 
mutations. This approa~~ has been used ~o ide?-tify mutations ~d 
keratin 1 in several famlhes [40,41]. Kerat1l1 10 IS the co-exp:ess h 
partner of keratin 1, both of which are required to form KIF In t . e 
cells of the suprabasallayers of the epidermis. Filament clu~ps In 
EHK have been shown to con~a~n ~oth th~se keratins [18]. It IS nOd 
surprising then, that abnormallt1es 111 ke~at111 1.0 could also be fO~d 
associated with EHK. Recently, several1l1vesttgators have repor~ 
keratin 10 mutations in EHK [40-42]. One keratin 10 mutatl~ll 
described in several families is a change from arginine to histidine ~1l 
the tenth codon of the helical rod domain. The same mutatiol~ It 
the analogous codon in keratin 14 has been implicated in the etlO -
ogy of EBS [43]. 
Clinical Heterogeneity in EHK In his original article in 19~Z: 
Brocq [44] described epidermolytic hyperkeratosis as "bullous Ie 
thyotic erythroderma" (BIE) and distinguished this conditIOn. f~ol 
non-blistering congenital ichthyotic erythroderma. The onglna 
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description included three unrelated patients with a blistering ich-
thyosis whose clinical manifestations varied by the presence of pal-
mar/plantar hyperkeratosis, quality of scale, and persistence of er-
ythroderma into adulthood. Based on clinical and ultrastructural 
features variants of EHK have since been described and include ichthyo~is bullosa of Siemens and ichthyosis hystrix of Curth-
Macklin . Siemens described a localized ichthyosis bullosa that 
lacked erythroderma and spared the palms and soles [45]. Curth and 
Macklin described two siblings with "thickened, verrucous black 
and hyperkeratotic skin," who had involvement of the palms as 
confluent plaques and contractures [46]. . 
Although clinical heterogeneity has previously been observed 111 
EHK, the distinctions have not been clear. In an effort to better 
define and characterize the specific clinical features of this disorder 
We have examined 52 patients with histologically confirmed EHK 
from 21 families .-r Patients were evaluated and graded for involve-
ment of the palms and soles, scalp, extensor vs. flexor areas, ery-
thema, infection, and blisters . 
Within this group of patients we have distinguished at least six 
clinical phenotypes. We found several features were useful for 
separating patients into clinical subtypes. The most distinctive char-
acteristic was presence versus absence of severe palmar/plantar hy-
perkeratosis. Twenty-nine patients in six families had this find~g. 
These patients were grouped into the PS (palm/sole hyperkeratosls) 
types. The remaining 15 families (23 patients) were classified as 
NPS (no palm/sole hyperkeratosis) types. On the basis of additional 
chnical characteristics, we further identified three distinct PS types 
and three NPS types. These six subtypes were distinguished by 
presence/absence of erythroderma, quality of scale, extent of in-
volvement, presence of digital contractures, and gait abnormali~. 
We have reviewed the descriptions of BIE of Brocq, ichthyoSlS 
bUllosa of Siemens, and ichthyosis hystrix of Curth-Macklin. 
Brocq's patients, with their variable clinical features, were not ho-
mogeneous and would fit into several different categories. Siemens 
description of ichthyosis bullosa is similar to one of our mild NPS 
categories. We did not observe patients with clinical findings de-
fined by Curth and Macklin. 
We and others are continuing to search for and characterize mu-
tations in keratin 1 and 10 in EHK. The correlation of the clinical 
disease subtypes with the specific mutations should lead to a better 
understanding of the relationship between keratin structure and 
function in normal and diseased epidermis. Ultimately, this will 
lead to a disease classification based upon the specific underlying 
molecular defect. 
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